.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Fish and Richardson
Novartis
Fuji
Teva
Deloitte
Citi
Cantor Fitzgerald
Boehringer Ingelheim
McKinsey

Generated: December 14, 2017

DrugPatentWatch Database Preview

Claims for Patent: 5,344,840

« Back to Dashboard

Claims for Patent: 5,344,840

Title: 4-substituted imidazole derivatives useful in perioperative care
Abstract:4-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole, known as medetomidine, and in particular its d-enantiomer and salts thereof are useful in perioperative care, in particular in reducing the amount of anaesthetic it is necessary to administer.
Inventor(s): Maze; Mervyn (Portola Valley, CA), Scheinin; Mika (Naantali, FI)
Assignee: Orion-Yhtyma OY (Turku, FI)
Application Number:08/003,681
Patent Claims: 1. A method of perioperative treatment of mammals to reduce the responses of the autonomic nervous system to stressful stimuli during an operation by administering to said mammal in whom such reduction is desired an effective amount of dextro 4-[1-(2,3-dimethylpheny)-ethyl] -1H-imidazole or a non-toxic pharmaceutically acceptable salt thereof substantially in the absence of the laevo form of said compound.

2. A method according to claim 1 wherein the compound is administered as anxiolytic analgesic premedication prior to an operation with or without the administration of an amount of anaesthetic sufficient to achieve a desired level of local or general anaesthesia.

3. A method according to claim 1 wherein the compound is administered preoperatively as sedative analgesic to potentiate the effect of an anaesthetic and thus to reduce the amount of anaesthetic required to achieve a desired level of anaesthesia.
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Dow
Express Scripts
Novartis
AstraZeneca
Accenture
Colorcon
Fish and Richardson
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot